Poly(γ,l-glutamic acid)–cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice
- 31 December 2006
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 27 (35), 5958-5965
- https://doi.org/10.1016/j.biomaterials.2006.08.016
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Preparation of nanoparticles composed of poly(γ-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cellsJournal of Controlled Release, 2005
- Multivalent Conjugates of Poly-γ-d-glutamic Acid fromBacillus licheniformiswith Antibody F(ab‘) and Glycopeptide LigandsBioconjugate Chemistry, 2003
- Poly(l-glutamic acid)–anticancer drug conjugatesAdvanced Drug Delivery Reviews, 2002
- Delivery of molecular and cellular medicine to solid tumorsAdvanced Drug Delivery Reviews, 2001
- Poly(glutamic Acid) for Biomedical ApplicationsCritical Reviews in Biotechnology, 2001
- Functional polymers in drug delivery: carrier-supported CDDP (cis-platin) complexes of polycarboxylates — effect on human ovarian carcinomaReactive and Functional Polymers, 1998
- Cisplatin-induced renal toxicity and toxicity-modulating strategies: a reviewCancer Chemotherapy and Pharmacology, 1994
- Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivoBioconjugate Chemistry, 1992
- Blood levels and serum protein binding of cis-Platinum(II) complexed to carboxymethyl-dextranCancer Chemotherapy and Pharmacology, 1989
- Effect of molecular weight (Mw) ofN‐(2‐hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to ratsJournal of Biomedical Materials Research, 1987